BeOne Medicines revenue and financials
$362.78Change from previous close: +0.31%Absolute change: +$1.13
In the fiscal year ended December 2025, BeOne Medicines reported revenue of $5.34B (+40.23% year over year). Net income was $286.93M, a net margin of 5.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +40.23%
- 2025 vs 2024
- Net margin
- 5.4%
- 2024: -16.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9,176 | 8,554 | 8,189 | 7,633 | 6,298 | 5,842 | 5,921 | 5,824 | 5,712 | 5,668 | 5,805 | 5,525 |
| Current assets | 7,216 | 6,601 | 6,234 | 5,664 | 4,310 | 3,896 | 3,992 | 3,911 | 3,839 | 3,908 | 4,203 | 4,054 |
| Cash and equivalents | 5,098 | 4,792 | 4,548 | 4,037 | 2,756 | 2,516 | 2,627 | 1,746 | 2,593 | 2,793 | 3,172 | 3,067 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | 107 |
| Receivables | 1,071 | 948 | 887 | 902 | 880 | 746 | 709 | 605 | 588 | 467 | 396 | 355 |
| Inventory | 733 | 682 | 608 | 532 | 503 | 495 | 495 | 432 | 443 | 447 | 416 | 317 |
| Net property, plant and equipment | 1,789 | 1,786 | 1,790 | 1,768 | 1,762 | 1,745 | 1,718 | 1,575 | 1,620 | 1,506 | 1,419 | 1,277 |
| Other intangible assets | 61.0 | 61.7 | 62.7 | 63.6 | 64.9 | 50.1 | 51.1 | 122 | 53.7 | 55.2 | 57.1 | 53.7 |
| Long-term investments | 66.1 | 66.0 | 61.7 | 101 | 119 | 121 | 129 | 35.2 | 140 | 144 | 89.6 | 89.3 |
| Current liabilities | 2,119 | 1,812 | 1,829 | 2,368 | 2,210 | 1,984 | 2,215 | 2,018 | 1,939 | 1,882 | 1,810 | 1,283 |
| Accounts payable | 470 | 424 | 479 | 384 | 361 | 364 | 405 | 476 | 333 | 357 | 315 | 342 |
| Long-term debt | 1,699 | 1,794 | 1,812 | 972 | 146 | 160 | 166 | 188 | 185 | 199 | 198 | 202 |
| Total debt | 1,143 | 1,149 | 1,093 | 1,020 | 1,026 | — | — | — | — | — | — | — |
| Total liabilities | 4,002 | 3,793 | 3,827 | 3,503 | 2,528 | 2,342 | 2,589 | 2,378 | 2,346 | 2,307 | 2,268 | 1,762 |
| Total equity (incl. minority) | 5,174 | 4,760 | 4,361 | 4,129 | 3,770 | 3,500 | 3,332 | 3,446 | 3,366 | 3,360 | 3,537 | 3,763 |
| Retained earnings | -7,856 | -8,093 | -8,320 | -8,386 | -8,511 | -8,606 | -8,607 | -8,750 | -8,334 | -8,213 | -7,962 | -7,594 |